Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer

As an aggressive subtype of breast cancer, triple-negative breast cancer (TNBC) is associated with poor prognosis and lack of effective therapy, except chemotherapy. In recent years, immunotherapy based on immune checkpoint (IC) inhibition has emerged as a promising therapeutic strategy in TNBC. TNB...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Qiaorui, Yin, Sha, Zhou, Dongdong, Chi, Yajing, Man, Xiaochu, Li, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134495/
https://www.ncbi.nlm.nih.gov/pubmed/35646659
http://dx.doi.org/10.3389/fonc.2022.779786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134495/
https://www.ncbi.nlm.nih.gov/pubmed/35646659
http://dx.doi.org/10.3389/fonc.2022.779786

Ejemplares similares